http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04178381-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97ddd4d1d0ebc8a7d2c8e7d214d08cf3
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
filingDate 1990-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19acf5523feb8c12a100cbdd513b0396
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13b0017a4ff66f36a3d4b730442600fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6300a72a477b9b2ee1c53f63d1fb84ab
publicationDate 1992-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H04178381-A
titleOfInvention Imidazolyl group-containing condensed seven-membered ring compound
abstract NEW MATERIAL:A compound shown by formula I {X is O, methylene, S or -NR 5 -; R 1 and R 2 are H, halogen, lower alkyl, lower alkoxy, etc.; one of R 3 and R 4 is group shown by formula II [-Y- is -(CH 2 ) n - (n is 0 or 1) or -NR 6 -] and the other is H, lower alkyl, (substituted) aromatic or heterocyclic ring; R 5 and R 6 are H, lower alkyl, acyl, etc.; broken line is single bond or double bond}. n EXAMPLE: 5-(4,5-Dihydro-1H-imidazol-2-y1)-2,3,4,5-tetrahydrobenzoxepin hydrochloride. n USE: A medicine for diabetes having excellent blood sugar lowering action and inhibitory action on blood platelet aggregation. n PREPARATION: A compound shown by formula III is subjected to cyanophosphonation, then reacted with boron trifluoride ether complex to give an α,β-unsaturated nitrile derivative shown by formula IV, which is reacted with p-toluenesulfonate of ethylenediamine under heating. n COPYRIGHT: (C)1992,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8383839-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7910751-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5981510-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007010383-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005523925-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6242431-B1
priorityDate 1990-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409908092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3301
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235000830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67892800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450459896

Total number of triples: 46.